PubMed:26036195
Annnotations
Glycan-Motif
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 69-80 | https://glytoucan.org/Structures/Glycans/G43702JT | denotes | chondroitin |
| T2 | 92-103 | https://glytoucan.org/Structures/Glycans/G43702JT | denotes | Chondroitin |
| T3 | 226-250 | https://glytoucan.org/Structures/Glycans/G61418DU | denotes | N-acetyl-D-galactosamine |
GlyCosmos6-Glycan-Motif-Image
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 69-80 | Glycan_Motif | denotes | chondroitin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G43702JT |
| T2 | 92-103 | Glycan_Motif | denotes | Chondroitin | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G43702JT |
| T3 | 226-250 | Glycan_Motif | denotes | N-acetyl-D-galactosamine | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G61418DU |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-91 | Sentence | denotes | Isolation and characterization of monoclonal antibodies specific for chondroitin sulfate E. |
| TextSentencer_T2 | 92-301 | Sentence | denotes | Chondroitin sulfate E (CSE) is a polysaccharide containing mainly disaccharide units of D-glucuronic acid (GlcA) and 4,6-O-disulfated N-acetyl-D-galactosamine (GalNAc) residues (E-unit) in the amount of ∼ 60%. |
| TextSentencer_T3 | 302-364 | Sentence | denotes | CSE is involved in many biological and pathological processes. |
| TextSentencer_T4 | 365-515 | Sentence | denotes | In this study, we established new monoclonal antibodies, termed E-12C and E-18H, by using CSE that contained more than 70% of E-units as an immunogen. |
| TextSentencer_T5 | 516-599 | Sentence | denotes | These antibodies recognized CSE but not other CSs isomers or dermatan sulfate (DS). |
| TextSentencer_T6 | 600-761 | Sentence | denotes | We evaluated the reactivities of the antibodies to 6-O-sulfated CSA (6S-CSA) and DS (6S-DS) that possessed ∼ 60% of GalNAc (4S, 6S) moieties in their structures. |
| TextSentencer_T7 | 762-807 | Sentence | denotes | Neither of the antibodies reacted with 6S-DS. |
| TextSentencer_T8 | 808-922 | Sentence | denotes | The antibodies strictly distinguished the structural difference of GlcA and L-iduronic acid in the polysaccharide. |
| TextSentencer_T9 | 923-1034 | Sentence | denotes | Binding affinities of the antibodies were determined by a surface plasmon resonance assay using CSE and 6S-CSA. |
| TextSentencer_T10 | 1035-1149 | Sentence | denotes | The binding affinities were strongly associated with the molecular weight of CSE and the E-unit content of 6S-CSA. |
| TextSentencer_T11 | 1150-1237 | Sentence | denotes | Moreover, we demonstrated that the antibodies are applicable to histochemical analysis. |
| TextSentencer_T12 | 1238-1333 | Sentence | denotes | In conclusion, the new anti-CSE monoclonal antibodies specifically recognize the E-unit of CSE. |
| TextSentencer_T13 | 1334-1451 | Sentence | denotes | The antibodies will become useful tools for the investigation of the biological and pathological significance of CSE. |
| T1 | 0-91 | Sentence | denotes | Isolation and characterization of monoclonal antibodies specific for chondroitin sulfate E. |
| T2 | 92-301 | Sentence | denotes | Chondroitin sulfate E (CSE) is a polysaccharide containing mainly disaccharide units of D-glucuronic acid (GlcA) and 4,6-O-disulfated N-acetyl-D-galactosamine (GalNAc) residues (E-unit) in the amount of ∼ 60%. |
| T3 | 302-364 | Sentence | denotes | CSE is involved in many biological and pathological processes. |
| T4 | 365-515 | Sentence | denotes | In this study, we established new monoclonal antibodies, termed E-12C and E-18H, by using CSE that contained more than 70% of E-units as an immunogen. |
| T5 | 516-599 | Sentence | denotes | These antibodies recognized CSE but not other CSs isomers or dermatan sulfate (DS). |
| T6 | 600-761 | Sentence | denotes | We evaluated the reactivities of the antibodies to 6-O-sulfated CSA (6S-CSA) and DS (6S-DS) that possessed ∼ 60% of GalNAc (4S, 6S) moieties in their structures. |
| T7 | 762-807 | Sentence | denotes | Neither of the antibodies reacted with 6S-DS. |
| T8 | 808-922 | Sentence | denotes | The antibodies strictly distinguished the structural difference of GlcA and L-iduronic acid in the polysaccharide. |
| T9 | 923-1034 | Sentence | denotes | Binding affinities of the antibodies were determined by a surface plasmon resonance assay using CSE and 6S-CSA. |
| T10 | 1035-1149 | Sentence | denotes | The binding affinities were strongly associated with the molecular weight of CSE and the E-unit content of 6S-CSA. |
| T11 | 1150-1237 | Sentence | denotes | Moreover, we demonstrated that the antibodies are applicable to histochemical analysis. |
| T12 | 1238-1333 | Sentence | denotes | In conclusion, the new anti-CSE monoclonal antibodies specifically recognize the E-unit of CSE. |
| T13 | 1334-1451 | Sentence | denotes | The antibodies will become useful tools for the investigation of the biological and pathological significance of CSE. |
| T1 | 0-91 | Sentence | denotes | Isolation and characterization of monoclonal antibodies specific for chondroitin sulfate E. |
| T2 | 92-301 | Sentence | denotes | Chondroitin sulfate E (CSE) is a polysaccharide containing mainly disaccharide units of D-glucuronic acid (GlcA) and 4,6-O-disulfated N-acetyl-D-galactosamine (GalNAc) residues (E-unit) in the amount of ∼ 60%. |
| T3 | 302-364 | Sentence | denotes | CSE is involved in many biological and pathological processes. |
| T4 | 365-515 | Sentence | denotes | In this study, we established new monoclonal antibodies, termed E-12C and E-18H, by using CSE that contained more than 70% of E-units as an immunogen. |
| T5 | 516-599 | Sentence | denotes | These antibodies recognized CSE but not other CSs isomers or dermatan sulfate (DS). |
| T6 | 600-761 | Sentence | denotes | We evaluated the reactivities of the antibodies to 6-O-sulfated CSA (6S-CSA) and DS (6S-DS) that possessed ∼ 60% of GalNAc (4S, 6S) moieties in their structures. |
| T7 | 762-807 | Sentence | denotes | Neither of the antibodies reacted with 6S-DS. |
| T8 | 808-922 | Sentence | denotes | The antibodies strictly distinguished the structural difference of GlcA and L-iduronic acid in the polysaccharide. |
| T9 | 923-1034 | Sentence | denotes | Binding affinities of the antibodies were determined by a surface plasmon resonance assay using CSE and 6S-CSA. |
| T10 | 1035-1149 | Sentence | denotes | The binding affinities were strongly associated with the molecular weight of CSE and the E-unit content of 6S-CSA. |
| T11 | 1150-1237 | Sentence | denotes | Moreover, we demonstrated that the antibodies are applicable to histochemical analysis. |
| T12 | 1238-1333 | Sentence | denotes | In conclusion, the new anti-CSE monoclonal antibodies specifically recognize the E-unit of CSE. |
| T13 | 1334-1451 | Sentence | denotes | The antibodies will become useful tools for the investigation of the biological and pathological significance of CSE. |
GlyCosmos6-Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 69-80 | https://glytoucan.org/Structures/Glycans/G43702JT | denotes | chondroitin |
| T2 | 92-103 | https://glytoucan.org/Structures/Glycans/G43702JT | denotes | Chondroitin |
| T3 | 226-250 | https://glytoucan.org/Structures/Glycans/G61418DU | denotes | N-acetyl-D-galactosamine |
Glycosmos6-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 69-80 | http://www.glycoepitope.jp/epitopes/EP0081 | denotes | chondroitin |
| T2 | 92-103 | http://www.glycoepitope.jp/epitopes/EP0081 | denotes | Chondroitin |
GlycoBiology-FMA
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| _T1 | 45-55 | FMAID:167180 | denotes | antibodies |
| _T2 | 69-88 | FMAID:196838 | denotes | chondroitin sulfate |
| _T3 | 69-88 | FMAID:82837 | denotes | chondroitin sulfate |
| _T4 | 92-111 | FMAID:196838 | denotes | Chondroitin sulfate |
| _T5 | 92-111 | FMAID:82837 | denotes | Chondroitin sulfate |
| _T6 | 125-139 | FMAID:196779 | denotes | polysaccharide |
| _T7 | 125-139 | FMAID:196735 | denotes | polysaccharide |
| _T8 | 125-139 | FMAID:82785 | denotes | polysaccharide |
| _T9 | 125-139 | FMAID:82746 | denotes | polysaccharide |
| _T10 | 158-170 | FMAID:82744 | denotes | disaccharide |
| _T11 | 158-170 | FMAID:196733 | denotes | disaccharide |
| _T12 | 182-197 | FMAID:196793 | denotes | glucuronic acid |
| _T13 | 182-197 | FMAID:82798 | denotes | glucuronic acid |
| _T14 | 237-250 | FMAID:82792 | denotes | galactosamine |
| _T15 | 237-250 | FMAID:196787 | denotes | galactosamine |
| _T16 | 410-420 | FMAID:167180 | denotes | antibodies |
| _T17 | 522-532 | FMAID:167180 | denotes | antibodies |
| _T18 | 577-585 | FMAID:67104 | denotes | dermatan |
| _T19 | 577-585 | FMAID:165189 | denotes | dermatan |
| _T20 | 577-593 | FMAID:165192 | denotes | dermatan sulfate |
| _T21 | 637-647 | FMAID:167180 | denotes | antibodies |
| _T22 | 777-787 | FMAID:167180 | denotes | antibodies |
| _T23 | 812-822 | FMAID:167180 | denotes | antibodies |
| _T24 | 907-921 | FMAID:196735 | denotes | polysaccharide |
| _T25 | 907-921 | FMAID:82746 | denotes | polysaccharide |
| _T26 | 907-921 | FMAID:196779 | denotes | polysaccharide |
| _T27 | 907-921 | FMAID:82785 | denotes | polysaccharide |
| _T28 | 949-959 | FMAID:167180 | denotes | antibodies |
| _T29 | 981-988 | FMAID:146300 | denotes | surface |
| _T30 | 981-988 | FMAID:50594 | denotes | surface |
| _T31 | 1185-1195 | FMAID:167180 | denotes | antibodies |
| _T32 | 1281-1291 | FMAID:167180 | denotes | antibodies |
| _T33 | 1338-1348 | FMAID:167180 | denotes | antibodies |
uniprot-human
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 595-597 | http://www.uniprot.org/uniprot/P49366 | denotes | DS |
| T2 | 681-683 | http://www.uniprot.org/uniprot/P49366 | denotes | DS |
| T3 | 688-690 | http://www.uniprot.org/uniprot/P49366 | denotes | DS |
| T4 | 804-806 | http://www.uniprot.org/uniprot/P49366 | denotes | DS |
| T5 | 664-667 | http://www.uniprot.org/uniprot/Q13216 | denotes | CSA |
| T6 | 672-675 | http://www.uniprot.org/uniprot/Q13216 | denotes | CSA |
| T7 | 1030-1033 | http://www.uniprot.org/uniprot/Q13216 | denotes | CSA |
| T8 | 1145-1148 | http://www.uniprot.org/uniprot/Q13216 | denotes | CSA |
GlycoBiology-NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 34-44 | http://purl.bioontology.org/ontology/NCBITAXON/608684 | denotes | monoclonal |
| T2 | 321-325 | http://purl.bioontology.org/ontology/NCBITAXON/9973 | denotes | many |
| T3 | 399-409 | http://purl.bioontology.org/ontology/NCBITAXON/608684 | denotes | monoclonal |
| T4 | 422-428 | http://purl.bioontology.org/ontology/NCBITAXON/62951 | denotes | termed |
| T5 | 1270-1280 | http://purl.bioontology.org/ontology/NCBITAXON/608684 | denotes | monoclonal |
GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 81-88 | http://purl.obolibrary.org/obo/GO_0051923 | denotes | sulfate |
| T2 | 104-111 | http://purl.obolibrary.org/obo/GO_0051923 | denotes | sulfate |
| T3 | 586-593 | http://purl.obolibrary.org/obo/GO_0051923 | denotes | sulfate |
| T4 | 655-663 | http://purl.obolibrary.org/obo/GO_0051923 | denotes | sulfated |
| T5 | 199-203 | http://purl.obolibrary.org/obo/GO_0043879 | denotes | GlcA |
| T6 | 875-879 | http://purl.obolibrary.org/obo/GO_0043879 | denotes | GlcA |
GO-MF
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 45-55 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | antibodies |
| T2 | 410-420 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | antibodies |
| T3 | 522-532 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | antibodies |
| T4 | 637-647 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | antibodies |
| T5 | 777-787 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | antibodies |
| T6 | 812-822 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | antibodies |
| T7 | 949-959 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | antibodies |
| T8 | 1185-1195 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | antibodies |
| T9 | 1281-1291 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | antibodies |
| T10 | 1338-1348 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | antibodies |
| T11 | 907-930 | http://purl.obolibrary.org/obo/GO_0030247 | denotes | polysaccharide. Binding |
| T12 | 923-930 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | Binding |
| T13 | 1039-1046 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
| T14 | 923-930 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | Binding |
| T15 | 1039-1046 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
| T16 | 923-930 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | Binding |
| T17 | 1039-1046 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
| T18 | 923-930 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | Binding |
| T19 | 1039-1046 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
EDAM-topics
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 341-353 | http://edamontology.org/topic_0634 | denotes | pathological |
| T2 | 373-378 | http://edamontology.org/topic_3678 | denotes | study |
| T3 | 505-514 | http://edamontology.org/topic_2830 | denotes | immunogen |
| T4 | 1418-1430 | http://edamontology.org/topic_0634 | denotes | pathological |
EDAM-DFO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 260-268 | http://edamontology.org/data_1756 | denotes | residues |
| T2 | 354-363 | http://edamontology.org/operation_2409 | denotes | processes |
| T3 | 354-363 | http://edamontology.org/operation_0004 | denotes | processes |
| T4 | 422-428 | http://edamontology.org/data_0968 | denotes | termed |
| T5 | 750-760 | http://edamontology.org/data_0883 | denotes | structures |
| T6 | 850-860 | http://edamontology.org/data_0883 | denotes | structural |
| T7 | 1163-1175 | http://edamontology.org/operation_2246 | denotes | demonstrated |
| T8 | 1228-1236 | http://edamontology.org/operation_2945 | denotes | analysis |
| T9 | 1368-1373 | http://edamontology.org/data_0007 | denotes | tools |
GlyTouCan-IUPAC
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| GlycanIUPAC_T1 | 199-203 | "http://rdf.glycoinfo.org/glycan/G91489RT" | denotes | GlcA |
| GlycanIUPAC_T2 | 875-879 | "http://rdf.glycoinfo.org/glycan/G91489RT" | denotes | GlcA |
| GlycanIUPAC_T3 | 199-203 | "http://rdf.glycoinfo.org/glycan/G54004DL" | denotes | GlcA |
| GlycanIUPAC_T4 | 875-879 | "http://rdf.glycoinfo.org/glycan/G54004DL" | denotes | GlcA |
| GlycanIUPAC_T5 | 199-203 | "http://rdf.glycoinfo.org/glycan/G90208ZS" | denotes | GlcA |
| GlycanIUPAC_T6 | 875-879 | "http://rdf.glycoinfo.org/glycan/G90208ZS" | denotes | GlcA |
| GlycanIUPAC_T7 | 199-203 | "http://rdf.glycoinfo.org/glycan/G47973RQ" | denotes | GlcA |
| GlycanIUPAC_T8 | 875-879 | "http://rdf.glycoinfo.org/glycan/G47973RQ" | denotes | GlcA |
| GlycanIUPAC_T9 | 199-203 | "http://rdf.glycoinfo.org/glycan/G35471RR" | denotes | GlcA |
| GlycanIUPAC_T10 | 875-879 | "http://rdf.glycoinfo.org/glycan/G35471RR" | denotes | GlcA |
| GlycanIUPAC_T11 | 199-203 | "http://rdf.glycoinfo.org/glycan/G45399NV" | denotes | GlcA |
| GlycanIUPAC_T12 | 875-879 | "http://rdf.glycoinfo.org/glycan/G45399NV" | denotes | GlcA |
| GlycanIUPAC_T13 | 199-203 | "http://rdf.glycoinfo.org/glycan/G52061FU" | denotes | GlcA |
| GlycanIUPAC_T14 | 875-879 | "http://rdf.glycoinfo.org/glycan/G52061FU" | denotes | GlcA |
| GlycanIUPAC_T15 | 199-203 | "http://rdf.glycoinfo.org/glycan/G10736YH" | denotes | GlcA |
| GlycanIUPAC_T16 | 875-879 | "http://rdf.glycoinfo.org/glycan/G10736YH" | denotes | GlcA |
| GlycanIUPAC_T17 | 199-203 | "http://rdf.glycoinfo.org/glycan/G30254CI" | denotes | GlcA |
| GlycanIUPAC_T18 | 875-879 | "http://rdf.glycoinfo.org/glycan/G30254CI" | denotes | GlcA |
| GlycanIUPAC_T19 | 199-203 | "http://rdf.glycoinfo.org/glycan/G57856MN" | denotes | GlcA |
| GlycanIUPAC_T20 | 875-879 | "http://rdf.glycoinfo.org/glycan/G57856MN" | denotes | GlcA |
| GlycanIUPAC_T21 | 199-203 | "http://rdf.glycoinfo.org/glycan/G95754KF" | denotes | GlcA |
| GlycanIUPAC_T22 | 875-879 | "http://rdf.glycoinfo.org/glycan/G95754KF" | denotes | GlcA |
| GlycanIUPAC_T23 | 199-203 | "http://rdf.glycoinfo.org/glycan/G90067UQ" | denotes | GlcA |
| GlycanIUPAC_T24 | 875-879 | "http://rdf.glycoinfo.org/glycan/G90067UQ" | denotes | GlcA |
| GlycanIUPAC_T25 | 252-258 | "http://rdf.glycoinfo.org/glycan/G23425WZ" | denotes | GalNAc |
| GlycanIUPAC_T26 | 716-722 | "http://rdf.glycoinfo.org/glycan/G23425WZ" | denotes | GalNAc |
| GlycanIUPAC_T27 | 252-258 | "http://rdf.glycoinfo.org/glycan/G02874VH" | denotes | GalNAc |
| GlycanIUPAC_T28 | 716-722 | "http://rdf.glycoinfo.org/glycan/G02874VH" | denotes | GalNAc |
| GlycanIUPAC_T29 | 252-258 | "http://rdf.glycoinfo.org/glycan/G99699DW" | denotes | GalNAc |
| GlycanIUPAC_T30 | 716-722 | "http://rdf.glycoinfo.org/glycan/G99699DW" | denotes | GalNAc |
| GlycanIUPAC_T31 | 252-258 | "http://rdf.glycoinfo.org/glycan/G22074RM" | denotes | GalNAc |
| GlycanIUPAC_T32 | 716-722 | "http://rdf.glycoinfo.org/glycan/G22074RM" | denotes | GalNAc |
| GlycanIUPAC_T33 | 252-258 | "http://rdf.glycoinfo.org/glycan/G48535VZ" | denotes | GalNAc |
| GlycanIUPAC_T34 | 716-722 | "http://rdf.glycoinfo.org/glycan/G48535VZ" | denotes | GalNAc |
| GlycanIUPAC_T35 | 252-258 | "http://rdf.glycoinfo.org/glycan/G39738WL" | denotes | GalNAc |
| GlycanIUPAC_T36 | 716-722 | "http://rdf.glycoinfo.org/glycan/G39738WL" | denotes | GalNAc |
| GlycanIUPAC_T37 | 252-258 | "http://rdf.glycoinfo.org/glycan/G42313WU" | denotes | GalNAc |
| GlycanIUPAC_T38 | 716-722 | "http://rdf.glycoinfo.org/glycan/G42313WU" | denotes | GalNAc |
| GlycanIUPAC_T39 | 252-258 | "http://rdf.glycoinfo.org/glycan/G00393CK" | denotes | GalNAc |
| GlycanIUPAC_T40 | 716-722 | "http://rdf.glycoinfo.org/glycan/G00393CK" | denotes | GalNAc |
| GlycanIUPAC_T41 | 252-258 | "http://rdf.glycoinfo.org/glycan/G42649EX" | denotes | GalNAc |
| GlycanIUPAC_T42 | 716-722 | "http://rdf.glycoinfo.org/glycan/G42649EX" | denotes | GalNAc |
| GlycanIUPAC_T43 | 252-258 | "http://rdf.glycoinfo.org/glycan/G46880SB" | denotes | GalNAc |
| GlycanIUPAC_T44 | 716-722 | "http://rdf.glycoinfo.org/glycan/G46880SB" | denotes | GalNAc |
| GlycanIUPAC_T45 | 252-258 | "http://rdf.glycoinfo.org/glycan/G75599IR" | denotes | GalNAc |
| GlycanIUPAC_T46 | 716-722 | "http://rdf.glycoinfo.org/glycan/G75599IR" | denotes | GalNAc |
| GlycanIUPAC_T47 | 252-258 | "http://rdf.glycoinfo.org/glycan/G58985MU" | denotes | GalNAc |
| GlycanIUPAC_T48 | 716-722 | "http://rdf.glycoinfo.org/glycan/G58985MU" | denotes | GalNAc |
| GlycanIUPAC_T49 | 252-258 | "http://rdf.glycoinfo.org/glycan/G92517PO" | denotes | GalNAc |
| GlycanIUPAC_T50 | 716-722 | "http://rdf.glycoinfo.org/glycan/G92517PO" | denotes | GalNAc |
| GlycanIUPAC_T51 | 252-258 | "http://rdf.glycoinfo.org/glycan/G88512YL" | denotes | GalNAc |
| GlycanIUPAC_T52 | 716-722 | "http://rdf.glycoinfo.org/glycan/G88512YL" | denotes | GalNAc |
| GlycanIUPAC_T53 | 252-258 | "http://rdf.glycoinfo.org/glycan/G41473NX" | denotes | GalNAc |
| GlycanIUPAC_T54 | 716-722 | "http://rdf.glycoinfo.org/glycan/G41473NX" | denotes | GalNAc |
| GlycanIUPAC_T55 | 252-258 | "http://rdf.glycoinfo.org/glycan/G71089RB" | denotes | GalNAc |
| GlycanIUPAC_T56 | 716-722 | "http://rdf.glycoinfo.org/glycan/G71089RB" | denotes | GalNAc |
| GlycanIUPAC_T57 | 252-258 | "http://rdf.glycoinfo.org/glycan/G73485GZ" | denotes | GalNAc |
| GlycanIUPAC_T58 | 716-722 | "http://rdf.glycoinfo.org/glycan/G73485GZ" | denotes | GalNAc |
| GlycanIUPAC_T59 | 252-258 | "http://rdf.glycoinfo.org/glycan/G61406KC" | denotes | GalNAc |
| GlycanIUPAC_T60 | 716-722 | "http://rdf.glycoinfo.org/glycan/G61406KC" | denotes | GalNAc |
| GlycanIUPAC_T61 | 252-258 | "http://rdf.glycoinfo.org/glycan/G34412GZ" | denotes | GalNAc |
| GlycanIUPAC_T62 | 716-722 | "http://rdf.glycoinfo.org/glycan/G34412GZ" | denotes | GalNAc |
| GlycanIUPAC_T63 | 252-258 | "http://rdf.glycoinfo.org/glycan/G67209FP" | denotes | GalNAc |
| GlycanIUPAC_T64 | 716-722 | "http://rdf.glycoinfo.org/glycan/G67209FP" | denotes | GalNAc |
| GlycanIUPAC_T65 | 252-258 | "http://rdf.glycoinfo.org/glycan/G61442IL" | denotes | GalNAc |
| GlycanIUPAC_T66 | 716-722 | "http://rdf.glycoinfo.org/glycan/G61442IL" | denotes | GalNAc |
| GlycanIUPAC_T67 | 252-258 | "http://rdf.glycoinfo.org/glycan/G93729MV" | denotes | GalNAc |
| GlycanIUPAC_T68 | 716-722 | "http://rdf.glycoinfo.org/glycan/G93729MV" | denotes | GalNAc |
| GlycanIUPAC_T69 | 252-258 | "http://rdf.glycoinfo.org/glycan/G92144AE" | denotes | GalNAc |
| GlycanIUPAC_T70 | 716-722 | "http://rdf.glycoinfo.org/glycan/G92144AE" | denotes | GalNAc |
GlycoBiology-Motifs
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 69-80 | http://rdf.glycoinfo.org/glycan/G00018MO | denotes | chondroitin |
| T2 | 92-103 | http://rdf.glycoinfo.org/glycan/G00018MO | denotes | Chondroitin |
| T3 | 69-88 | http://rdf.glycoinfo.org/glycan/G00018MO | denotes | chondroitin sulfate |
| T4 | 92-111 | http://rdf.glycoinfo.org/glycan/G00018MO | denotes | Chondroitin sulfate |
| T5 | 577-593 | http://rdf.glycoinfo.org/glycan/G00019MO | denotes | dermatan sulfate |
Lectin
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| Lectin_T1 | 664-667 | https://acgg.asia/db/lfdb/LfDB0192 | denotes | CSA |
| Lectin_T2 | 672-675 | https://acgg.asia/db/lfdb/LfDB0192 | denotes | CSA |
| Lectin_T3 | 1030-1033 | https://acgg.asia/db/lfdb/LfDB0192 | denotes | CSA |
| Lectin_T4 | 1145-1148 | https://acgg.asia/db/lfdb/LfDB0192 | denotes | CSA |
GlycoBiology-Epitope
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-GlycoEpitope-B_T1 | 69-80 | http://www.glycoepitope.jp/epitopes/EP0081 | denotes | chondroitin |
| PD-GlycoEpitope-B_T2 | 92-103 | http://www.glycoepitope.jp/epitopes/EP0081 | denotes | Chondroitin |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 664-667 | Disease | denotes | CSA | http://purl.obolibrary.org/obo/MONDO_0019569 |
| T2 | 672-675 | Disease | denotes | CSA | http://purl.obolibrary.org/obo/MONDO_0019569 |
| T3 | 1030-1033 | Disease | denotes | CSA | http://purl.obolibrary.org/obo/MONDO_0019569 |
| T4 | 1145-1148 | Disease | denotes | CSA | http://purl.obolibrary.org/obo/MONDO_0019569 |
GlyCosmos15-Glycan
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 69-80 | Glycan | denotes | chondroitin | https://api.glycosmos.org/wurcs2image/latest/png/binary/G43702JT |
| T2 | 92-103 | Glycan | denotes | Chondroitin | https://api.glycosmos.org/wurcs2image/latest/png/binary/G43702JT |
| T3 | 252-258 | Glycan | denotes | GalNAc | https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL |
| T4 | 716-722 | Glycan | denotes | GalNAc | https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL |
Glycosmos15-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
|---|---|---|---|---|---|
| T1 | 69-80 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | chondroitin | http://www.glycoepitope.jp/epitopes/EP0081 |
| T2 | 92-103 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Chondroitin | http://www.glycoepitope.jp/epitopes/EP0081 |